These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11480400)

  • 21. [Topics on transporter-mediated renal excretion and drug-drug interaction].
    Mizuuchi H
    Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):30-3. PubMed ID: 20075568
    [No Abstract]   [Full Text] [Related]  

  • 22. Overview of drug discovery and development.
    Ator MA; Mallamo JP; Williams M
    Curr Protoc Pharmacol; 2006 Dec; Chapter 9():Unit9.9. PubMed ID: 22294181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug metabolism and pharmacokinetics in support of drug design.
    Tang W; Lu AY
    Curr Pharm Des; 2009; 15(19):2170-83. PubMed ID: 19601821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.
    Gordon EM; Barrett RW; Dower WJ; Fodor SP; Gallop MA
    J Med Chem; 1994 May; 37(10):1385-401. PubMed ID: 8182695
    [No Abstract]   [Full Text] [Related]  

  • 25. Erlotinib and gastric acid-reducing agents: a combination to avoid or to support?
    Oude Munnink TH; Schouwink JH; Colen HB; Movig KL
    Clin Pharmacol Ther; 2014 Dec; 96(6):658. PubMed ID: 25117906
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacology of drug metabolism and drug interactions: clinical, interethnical and regulatory aspects.
    Llerena A
    Drug Metabol Drug Interact; 2013; 28(1):1-3. PubMed ID: 23449520
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.
    Camenisch G; Umehara K
    Biopharm Drug Dispos; 2012 May; 33(4):179-94. PubMed ID: 22407504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to "erlotinib and gastric Acid-reducing agents: a combination to avoid or to support?".
    Zhang L; Lee SC; Zhao H; Wu F; Zhang L
    Clin Pharmacol Ther; 2014 Dec; 96(6):659. PubMed ID: 25247623
    [No Abstract]   [Full Text] [Related]  

  • 30. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical relevance of drug transporter malfunctions.
    Lancaster CS; Sparreboom A
    Clin Pharmacol Ther; 2011 Apr; 89(4):471-4. PubMed ID: 21423235
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug Discovery Technology Europe 2007--An Informa Conference. Better tools for early decision-making. 12-15 March 2007, London, UK.
    Terrett N
    IDrugs; 2007 May; 10(5):320-3. PubMed ID: 17487783
    [No Abstract]   [Full Text] [Related]  

  • 33. The methylation effect in medicinal chemistry.
    Barreiro EJ; Kümmerle AE; Fraga CA
    Chem Rev; 2011 Sep; 111(9):5215-46. PubMed ID: 21631125
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical solids: a strategic approach to regulatory considerations.
    Byrn S; Pfeiffer R; Ganey M; Hoiberg C; Poochikian G
    Pharm Res; 1995 Jul; 12(7):945-54. PubMed ID: 7494814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conference Report: ESF-COST High-Level Research Conference Natural Products Chemistry, Biology and Medicine III.
    Catino A
    Future Med Chem; 2010 Dec; 2(12):1797-803. PubMed ID: 21428802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Information requirements for chemists in the pharmaceutical industry.
    Brown HD
    J Chem Inf Comput Sci; 1984 Aug; 24(3):155-8. PubMed ID: 6480718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access.
    Rekić D; Reynolds KS; Zhao P; Zhang L; Yoshida K; Sachar M; Piquette Miller M; Huang SM; Zineh I
    J Pharm Sci; 2017 Sep; 106(9):2214-2218. PubMed ID: 28435142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial human trials with an investigational new drug (phase I and 2): planning an management.
    Vaidya AB; Vaidya RA
    J Postgrad Med; 1981 Oct; 27(4):197-213. PubMed ID: 7338825
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives.
    Humphrey MJ; Smith DA
    Xenobiotica; 1992 Jul; 22(7):743-55. PubMed ID: 1455898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.